Call Options Transactions Made in Q3 2023 in Mirati Therapeutics, Inc. (MRTX)
This table provides information about the institutional ownership of Mirati Therapeutics, Inc. (MRTX) during Q3 2023. The information is specifically focused on institutions that hold call options of Mirati Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Artal Group S.A.
Luxembourg, N4 |
BUY
|
CALL |
450K+ 180.0% |
$12.5M - $20.4M
|
700K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
CALL |
100KNew |
$2.78M - $4.54M
|
100K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
82.1KNew |
$2.28M - $3.72M
|
82.1K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
49.9K+ 90.07% |
$1.39M - $2.26M
|
105K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
31K+ 262.71% |
$862K - $1.41M
|
42.8K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
22.8K+ 253.33% |
$634K - $1.03M
|
31.8K
$0
|
|
|
Nov 15, 2023
Q3 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
14.9KNew |
$414K - $676K
|
14.9K
$0
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
BUY
|
CALL |
11KNew |
$306K - $499K
|
11K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
BUY
|
CALL |
10.8KNew |
$300K - $490K
|
10.8K
$0
|
|
|
Nov 15, 2023
Q3 2023
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
8.7K+ 102.35% |
$242K - $395K
|
17.2K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
900+ 20.93% |
$25K - $40.8K
|
5.2K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Moore Capital Management, LP
New York, NY |
SELL
|
CALL |
-86.9K- 86.9% |
$2.42M - $3.94M
|
13.1K
$0
|